Omada Health reported cash from operations of $4.01M and free cash flow of $2.49M for the quarter ended Jun 2026, up 40.2% year over year. This cash flow statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | -10.69M | -9.23M | -8.25M | -9.45M | -5.31M | -3.18M | 5.16M | -2.97M | 5.29M |
| Share-based CompensationStock Comp. | 2.16M | 2.31M | 2.84M | 2.83M | 3.54M | 3.75M | 4.21M | 5.63M | |
| Gains from Investment SecuritiesGains Investment | -0.39M | -0.43M | 0.23M | 0.52M | 0.74M | 0.21M | |||
| Asset Writedowns and ImpairmentWritedown | -0.33M | 0.26M | 1.01M | 0.63M | -0.14M | 0.99M | -0.30M | 0.81M | 0.38M |
| Cash from OperationsCash from Ops. | 1.06M | -6.49M | -16.12M | 2.86M | 10.13M | 21.38M | -11.83M | 4.01M | |
| Depreciation, Depletion & Amortization | |||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.18M | 0.19M | 0.19M | 0.19M | 0.07M | ||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.10M | 0.10M | 0.11M | 0.14M | 0.03M | ||||
| Depreciation & Amortization (CF)Dep. & Amort. | 1.23M | 1.28M | 1.33M | 1.35M | 1.36M | 1.45M | 1.51M | 1.58M | |
| Change in Working Capital | |||||||||
| Change in ReceivablesChange Receivables | -0.16M | -0.87M | 6.50M | 3.86M | 9.15M | -7.16M | 6.21M | 16.97M | |
| Change in InventoryChange Inventory | -0.36M | 1.53M | -0.25M | 0.43M | -0.32M | 1.34M | -0.66M | 0.29M | |
| Change in Account PayablesChange Payables | 2.66M | -1.09M | 0.28M | 0.73M | 0.36M | 4.92M | -2.12M | 3.65M | |
| Change in Accured ExpensesChange Accured Exp. | 4.74M | 3.66M | -8.43M | 3.65M | 12.56M | 2.77M | -9.16M | 4.75M | |
| Other Working Capital ChangesOther WC Changes | -0.43M | -3.18M | 3.26M | 2.74M | 1.63M | -2.10M | 4.29M | -1.65M | |
| Investing Activities | |||||||||
| Capital ExpendituresCapex | 0.99M | 0.79M | 0.93M | 0.98M | 1.45M | 1.15M | 1.48M | 1.52M | |
| Cash from Investing ActivitiesCash from Investing | -1.07M | -0.97M | -1.25M | -1.25M | -1.99M | -1.35M | -1.56M | -1.66M | |
| Financing Activities | |||||||||
| Other financing activitiesOther financing | 0.67M | 1.28M | 0.92M | 159.61M | 3.25M | 8.14M | |||
| Cash from Financing ActivitiesCash from Financing | -0.42M | 0.11M | 0.37M | 162.14M | -32.66M | 3.38M | 3.12M | 7.60M | |
| Additional items | |||||||||
| Change in Cash | -0.44M | -7.34M | -17.00M | 163.75M | -24.52M | 23.41M | -10.27M | 9.95M | |
| Free Cash FlowFCF | 0.06M | -7.27M | -17.05M | 1.88M | 8.68M | 20.23M | -13.31M | 2.49M | |
| Net Cash FlowNCF | -0.44M | -7.34M | -17.00M | 163.75M | -24.52M | 23.41M | -10.27M | 9.95M |